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Abstract
Lower urinary tract dysfunction (LUTD) is common in both men and women, 
and the incidence and prevalence increases as people age. Commonly observed 
symptoms of LUTD include nocturia, urgency, urinary incontinence and frequency 
of voiding. Recognizing the key role accurate monitoring and evaluation of LUTD 
play in the day-to-day assessment of the condition, this chapter will explore the 
diagnostic capabilities of imaging modalities including MRI, ultrasound and 
fluoroscopy in assessing bladder wall thickness (BWT), detrusor wall thickness 
(DWT) and estimation of bladder weight both in real-time and static positions, and 
finally analyze their suitability as surrogates for bladder outlet obstruction (BOO) 
or detrusor overactivity (DO).
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1. Introduction
The lower urinary tract (LUT), consisting of the urinary bladder and urethra, 
functions to store and expel urine in a controlled and coordinated manner [1, 2]. 
This key function is dependent upon neural circuits located in the central and 
peripheral nervous system (CNS) (brain, peripheral ganglia, spinal cord and 
brain) [1], thus distinguishing LUT from other visceral structures such as cardio-
vascular system and gastrointestinal tract, that are able to sustain a certain level of 
activity even after elimination of extrinsic neural input [3]. Considering the fact 
that control over urine storage and voiding is somehow complex and also depen-
dent on neurological elements widely distributed in anatomical terms, the function 
of LUT can be affected by a myriad of neurological diseases and disorders of the 
peripheral organs [4].
Lower urinary tract dysfunctions (LUTD) may thus result from lesions affect-
ing the brain, suprasacral spinal cord and sacral spinal cord or peripheral nerve 
[5]. Lesions affecting the suprasacral or spinal pathways affect the storage phase, 
leading to reduced bladder capacity and detrusor overactivity, which is character-
ized by varying degrees of urinary frequency, urgency, incontinence and nocturia, 
while lesions of the sacral spinal cord pathways result in voiding dysfunction, 
associated with non-relaxing sphincter and/or absent or poorly sustained detrusor 
contractions [6]. As a result, functional disorders such as bladder outlet obstruction 
Lower Urinary Tract Dysfunction - From Evidence to Clinical Practice
2
secondary to prostatic enlargement, overactive bladder and urinary incontinence 
are common, as are prostate and bladder carcinoma [7].
Clinical assessment of LUDT may include tests such as post-void residual 
volume measurement, renal ultrasound, uroflowmetry, urethrocystoscopy, neu-
rophysiology and urodynamics depending on the indication [6]. Furthermore, 
urodynamic tests including filling cystometry and pressure flow study are consid-
ered as the gold standard methods for diagnosing detrusor overactivity (DO) and 
bladder outlet obstruction (BOO) respectively. The key issue with the urodynamic 
techniques is that, they are invasive and hence are associated with potential patient 
morbidity [8]. Therefore, there have been efforts over the years toward developing 
non-invasive techniques such as ultrasound, magnetic resonance imaging (MRI), 
fluoroscopy and near-infrared spectroscopy, with the potential of serving as suit-
able surrogates for diagnosing BOO and DO. Recognizing the key role these imaging 
modalities play in accurate monitoring and evaluation of LUTD, this chapter set out 
to explore their diagnostic potential in LUTD and finally examine their suitability 
as surrogates for the urodynamic tests.
2. The lower urinary tract
The lower urinary tract (LUT) consists of urinary bladder and urethra, and also 
includes the prostate in males. These organs are actively involved in the involuntary 
storage of urine formed in the upper urinary tract and the voluntary expulsion of 
urine at a suitable place and time [7]. The effectiveness of these functions depend 
on the activity of striated and smooth muscles in the bladder, urethra and external 
urethral sphincter, which is in turn controlled by neural circuits in the spinal cord, 
peripheral ganglia and brain [4]. Owning to the differences in sexual function and 
pelvic anatomy, there are considerable differences in the anatomy of LUT in males 
and females.
The bladder is a hollow organ located within the pelvis. Its wall consists of five 
layers from inside out, and the muscle of the bladder, the detrusor, is composed of 
smooth muscle fibers [9]. The wall thickness of the bladder decreases from 2 cm to 
2 mm during expansion. The principal function of the bladder is that of a reservoir, 
storing urine at lower pressures, even with large filling volumes. The normal blad-
der holds 200–500 ml urine, and for imaging assessment, a full bladder is preferred 
for visualization. Due to the visco-elastic properties of the bladder wall and the 
inhibition of the filling phase detrusor contractions, the bladder is compliant and 
the pressure inside usually remain low [10]. In the clinical assessment of images of 
the LUT, it is important to note the close relation between the anterior vaginal wall 
and the urethra in women and between seminal vesicles and prostate and posterior 
urethra and the bladder base in men [11].
2.1 Lower urinary tract dysfunction (LUTD)
The primary physiological functions of the LUT are the storage of urine (at 
relatively low pressure) and its voiding (expulsion) at appropriate time. LUT 
dysfunction is a common problem, and the prevalence increases with ageing. The 
term “dysfunction” indicates an abnormality in the physiology of the lower uri-
nary tract, including urinary sphincter, associated nervous system, bladder neck 
and detrusor muscle. This may result in failure to store urine, failure to empty or a 
combination of both [12]. Lower urinary tract symptoms can thus be divided into 
storage phase symptoms, voiding phase symptoms and postmicturition symp-
toms. These symptoms can be caused by various types of bladder dysfunctions 
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such as overactive bladder, underactive bladder, urinary tract infections and 
neurogenic disorders [13]. Storage symptoms include increased nocturia, daytime 
frequency, urgency and incontinence. Voiding symptoms include splitting or 
spraying, slow stream, intermittency, hesitancy, straining and terminal dribble. 
Post micturition symptoms include a feeling of incomplete emptying and post 
micturition dribble [14].
2.1.1 Bladder outlet obstruction (BOO)
Voiding as intended by nature should result in complete emptying of the blad-
der. This depends on a coordinated contraction of the detrusor smooth muscle with 
a simultaneous lowering of bladder outlet resistance. Distortion, compression or 
occlusion of the outlet of the bladder obstructs urine flow during expulsion, with 
attendant characteristic symptoms of dribbling, poor stream, incomplete emptying 
and hesitancy. Bladder outlet obstruction (BOO) is an indication of the existence 
of abnormal tissue which modifies the configuration of the bladder outlet through 
distortion, compression or occlusion, thus impeding the urine flow at the time 
of expulsion. Accompanying urine symptoms include slow stream, intermittent 
stream, hesitancy, straining to void, terminal dribble, post-micturition dribble and 
feeling of incomplete emptying [15].
These LUT symptoms are caused by a variety of different pathologies. The 
commonest processes responsible for BOO in men are benign prostatic enlarge-
ment (BPE) or urethral stricture disease [15]. For lesser degrees of obstruction, 
the symptomatic consequences may be slight, owing to compensatory responses, 
such as enhanced bladder contractility. However, a potential feature of BPE is 
the progression of obstruction with ageing, which leads to evident expulsion and 
post-micturition LUT symptoms. Also, the emergence of LUT symptoms point to 
relative inadequacy in the expulsive capacity of the bladder, which may be a con-
sequence of detrusor underactivity. Detrusor underactivity is characterized by a 
contraction of reduced duration and/or strength, thus resulting in failure to achieve 
complete bladder emptying within regular time span and/or prolonged bladder 
emptying. The variables of detrusor contraction strength, contraction duration 
and outlet obstruction severity leads to varied clinical features of BOO. The basis 
of obstruction in females may be bladder neck distortion, urethral compression or 
luminal occlusion and functional issues [16]. However, in women, due to difficulty 
in assessing bladder contractility, there is difficulty in arriving at decisions on issues 
regarding diagnosis of BOO [15]. Diagnosis of BOO can be made based on invasive 
urodynamic study, such as videourodynamic study or pressure flow study. Also, a 
noninvasive method to diagnose BOO is needed for more accurate treatment [17].
2.1.2 Overactive bladder (OAB) and detrusor overactivity (DO)
According to the International Continence Society (ICS), overactive bladder 
(OAB) is defined as a complex of urgency, usually with increased daytime fre-
quency and nocturia, with (OAB wet) or without (OAB dry) urinary incontinence. 
Urgency is the key symptom of OAB, and it is a sudden compelling desire to pass 
urine, which is difficult to defer [18]. In diagnosing OAB, it is assumed that con-
flicting issues such as, urinary tract infections are excluded. OAB might be because 
of increased bladder sensation or detrusor overactivity (DO). Confusion usually 
exists between these two disease states because patients usually cannot differentiate 
the sensation of urgency from the urge to void [19].
DO is an urodynamic observation characterized by involuntary detrusor con-
tractions during the filling phase that may be provoked or spontaneous. The ICS 
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2002 report categorizes DO into two types: (1) terminal, which is a single invol-
untary detrusor contraction that often results in complete bladder emptying; and 
(2) phasic, which may or may not lead to urinary incontinence. Therefore, OAB is 
a symptom-based diagnosis, while DO is an urodynamic diagnosis. A research on 
OAB and DOO showed that 64% of patients with OAB symptoms had DO on uro-
dynamic investigation, while 30% of the patients with DO did not have AOB [18].
3. Imaging modalities used for the clinical assessment of LUTD
The lower urinary tract (LUT) requires coordination of the prostate, bladder, 
pelvic floor, urethra, and specific spinal cord and brain areas. Different imaging 
modalities can be utilized to visualize these structures and are employed to study its 
pathophysiology and diagnose voiding dysfunction. Although the bladder and ure-
thra are anatomically distinct structures, they are functionally closely interrelated. 
Therefore, imaging of the bladder is often needed to confirm clinical examination.
Imaging modalities including ultrasound (US), voiding cystourethrogram 
X-ray (VCUG), magnetic resonance imaging (MRI), computed tomography (CT), 
positron emission tomography (PET) and functional magnetic resonance imaging 
(fMRI) are used to visualize the distinctive structures of the LUT. US is the com-
monly used technique in daily practice, to evaluate LUTD. The utilization of MRI 
for voiding dysfunction however remains limited, but several clinical studies have 
already shown its potential in the benign prostatic hyperplasia (BPH) and diagnosis 
of stress urinary incontinence. Also, PET and fMRI of the brain have made it pos-
sible to study supraspinal control of the LUT, in the light of LUT being subjected to 
a complex neural control mechanism.
Urodynamic tests have over the years been considered the gold standard method 
for diagnosing common conditions of the lower urinary tract such detrusor over-
activity (DO) and bladder outlet obstruction (BOO). However, with increasing 
concern about their “invasiveness” and associated potential patient morbidity, there 
has been a search towards non-invasive techniques such as ultrasound, computed 
tomography (CT), PET, magnetic resonance imaging (MRI), with the potential of 
becoming the mainstay diagnostic tools for LUTD. Furthermore, clinical assess-
ment of the urethral symptoms is challenging and often requires further evaluation 
with imaging.
3.1 Ultrasonography
Ultrasonography (US) has over the years emerged as the most widely used imag-
ing technique for the study of the LUT. In the past, US was identified as a technique 
of approach and guidance for the evaluation of LUT, but it is now recognized 
worldwide as the investigation of choice allowing precise diagnosis of many patho-
logical conditions of the LUT, usually obviating the need for further radiological 
examinations. For instance, Transabdominal US is a cheap and easy modality to 
evaluate structural abnormalities of the bladder, stone disease of the bladder, post-
void residual urine (PVR) or vesico-ureteral junction, neoplasms and inflammatory 
disorders [20].
The US, although simple to use, safe and acceptable by majority of patients, 
still remains real-time operator dependent, and in the light of new applications, 
requires experienced and skilled operator in whose hands often becomes the only 
exam needed to be able to direct the next phase of the diagnostic algorithm. Recent 
advances in US, incorporating a high resolution multi frequency transducers allows 
a meticulous study of the kidneys, its size, location and parenchymal structure, 
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including a thorough assessment of the urinary bladder, perivesical space as well 
as pelvicalyceal and ureteral dilatation [21]. The use of US requires when possible 
a full bladder which is not distended to the extent that the individual has pain. 
This is necessary because, it is only a well-distended bladder that allows true mass 
abnormalities to be seen, or else, apparent focal wall diverticula or masses can be 
stimulated by invaginations of the deflated bladder, usually obscuring true bladder 
lesions such as calculi by the non-distended bladder folds [22].
In the assessment of LUT using US, patients are normally examined in the 
supine position but sometimes is required when there is the need to differenti-
ate mobile intravesical abnormalities such as foreign bodies or stones from fixed 
lesions. The use of a 3.5–5-MHz curved array is normally acceptable for most US 
examinations of the LUT, however, with regards to anterior bladder wall, higher 
frequency linear probes are sometimes required for better resolution [22].
3.1.1 Ultrasonographic methods in the assessment of LUTD
Ultrasonography has proven to be essential in the evaluation of patients with 
lower urinary tract dysfunction (LUTD). This is based on the premise that LUTD 
may result in an alteration of the anatomic structures of the lower urinary tract 
(LUT) and vice versa [23]. In routine practice, US is mostly used to accurately 
measure the post-void residual urine (PVR) which indicates how completely an 
individual empties his bladder. Individuals with bladder outlet obstruction (BOO) 
and/or detrusor underactivity are commonly associated with elevated PVR [24]. 
The ultrasound measurement of bladder wall thickness (BWT) has also been linked 
to the diagnosis of overactive bladder (OAB) and BOO, with several studies report-
ing that increases in BWT can be a valuable biomarker for detrusor overactivity 
(DO) in subjects with an OAB syndrome [25, 26]. This is based on the assumption 
that increased BWT in BOO or OAB is secondary to hypertrophy of the detrusor 
wall, which is associated with increased isometric detrusor contraction against 
a competent urethral sphincter. These contractions lead to a rise in intravesical 
pressure, giving the individual a very strong desire to void [27]. Furthermore, 
it is generally accepted that an increase in mean BWT is unique to DO, with a 
study recording a statistically significant correlation between DO and BWT [27]. 
Detrusor wall thickness (DWT) might be a more accurate measure for BOO. A 
DWT >2 mm has been reported in 94% of men with signs of BOO on urodynamics 
[28]. In addition, measurement of DWT or BWT with US can used to examine the 
response to surgical or medical treatment of BOO. For instance, reduced BWT is 
detected after treatment with α-1 receptor blockers and transvesical prostatectomy 
[29, 30]. The ultrasonographic sections of the urinary bladder are defined from 
outside-in as bladder hyperechoic (adventitia), hypoechoic (detrusor muscle) and 
hyperechoic (bladder mucosa) [31, 32]. DWT measures only the middle layer, while 
the measurement of BWT involves all the three layers. The only issue with BWT 
measurement is that, it is volume dependent, and bladder wall thickness decrease 
with increasing filling volume. Hence, there is the need to measure bladder weight 
which should remain constant at different bladder volumes. Thus, with the aid 
of US, bladder weight is calculated from the thickness of the bladder wall and the 
intravesical volume assuming a spherical bladder (see Figure 1).
The benefit of utilizing US to monitor the deformation in the detrusor muscle 
have been shown by a recent study [33]. This provides insight into the detrusor 
muscle’s dynamic and structural properties related to bladder pressure. In the study, 
it was demonstrated that US could be used to estimate strain in the detrusor muscle, 
which was positively correlated with the detrusor pressure. This suggests a possibil-
ity of using US in a real time manner to monitor detrusor muscle activity. Also, this 
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finding is important because, it is an indication that US imaging could be used as a 
non-invasive modality option to replace the pressure flow studies which remain the 
standard diagnostic urodynamic tests for lower urinary tract symptoms (LUTS).
With recent advances in US imaging of the urethra, imaging of different struc-
tural abnormalities such as urethral neoplasms and urethral diverticulae are now 
possible. The typical symptoms of urethral diverticula are dyspareunia, urethral 
pain and post-voiding dribbling [34]. In addition, the multiplanar US allows imag-
ing of the size, location, content, and configuration of the diverticulum. Also, in 
the case of surgical planning, US allows the diverticulum neck can to be evaluated, 
together with the presence of calculi in sac [20].
3.1.2 Recent innovations in the field of ultrasonography
The recent years have seen an evolution in the field of ultrasonography, with 
the introduction of applications which have great importance in the assessment of 
LUT. These new applications include harmonic imaging, motion-mode, transperi-
neal US and 3D and 4D ultrasound.
Figure 1. 
(A) An ultrasound image of the urinary bladder (transverse scan) showing normal bladder wall thickness 
(BWT) (a, arrow) in a middle-aged woman with irritative lower urinary tract symptoms (LUTS) and 
normal filling cystometry (FCM); (B) ultrasound image (longitudinal scan) showing increased BWT (b, 
arrow) in a middle-aged man with irritative LUTS and detrusor overactivity [26].
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Harmonic imaging (HI) is based on the harmonic response generated by the 
tissue or, when used by the contrast medium, rather than on the reflection of the 
fundamental frequency of the ultrasound beam. This provides a better defini-
tion of the profiles, particularly of the fluid structure systems, such as reduces 
artifacts; improves the representation of the contrast medium; and dilated col-
lectors. Thus, HI removes low frequency sonic artifact which is usually the result 
of reverberation artifact and help better define the bladder wall. Motion-mode 
(M-mode) assists in the assessment of movement, and is therefore valuable in 
providing documentation and semiquantitative evaluation of ureteral peristalsis. 
Transperineal US, incorporating high-frequency linear probes allows ideal visu-
alization of the vagina, urethra and surrounding structures. 3D and 4D US offer 
a multiaxial illustration of the entire kidney and bladder, thus improving renal 
parenchymal volume calculation, mostly in hydronephrosis or irregularly shaped 
kidneys. This is possible because, the dilated collecting system can be deducted 
from the overall kidney volume. Also, the potential of creating rendered views will 
allow the comprehensive demonstration of complex pathology [21, 35].
3.2 Voiding cystourethrogram X-ray (VCUG) of LUTD
VCUG uses a small amount of radiation to make images of an individual’s uri-
nary system, and it enables the assessment of the bladder’s size and shape and also 
looks for abnormalities, such as a blockage along the path of the urine [36]. Images 
from VCUG can also show whether the urine is moving in the right direction. The 
normal flow of urine is from the kidneys down to the bladder through the ureters. 
However, in a condition called vesicoureteral (VU) reflux, urine flows backward 
from the bladder to one or both ureters and sometimes to the kidneys, and it some-
times occurs only at the voiding stage [37]. VU reflux can be detected by VCUG, 
which also includes taking X-ray images while the bladder is being emptied. This 
makes VCUG appropriate for diagnosing VU that only occurs while voiding [38].
During VCUG, a patient’s bladder is filled with contrast material, followed by an 
X-ray machine used to send beams of radiation through the abdomen and pelvis, 
and images are recorded on special film or a computer. These images help physicians 
see problems in parts of the urinary system, including the bladder, urethra (the tube 
connecting the bladder with the outside of the body), and the ureters (the tubes 
connecting the kidneys to the bladder) (LUT), aiding in diagnosing LUTDS [39].
3.3 Magnetic resonance imaging in the assessment of LUTD
Technological advancement in imaging modalities, allowing cross-sectional 
imaging of the LUT is essential for further functional and/or morphological evalu-
ation. Primary disorders for MRI of the LUT are bladder tumors and congenital 
abnormalities, and in addition, MRI is usually employed as a secondary imaging 
modality, particularly for assessing voiding dysfunction in pediatric urology [40]. 
MRI can also be used in conjunction with US for imaging of the size, content 
and position of the urethral diverticulae (see Figure 2). With regards to urethral 
neoplasms, MRI can reveal different characteristics of the different types of the 
neoplasms (see Figure 2). These neoplasms of the urethra appear as more heteroge-
neous lobulated, deeply infiltrating or exophytic lesions [20]. Urethral hypermobil-
ity can also be identified on both MR imaging and US, and it has been linked with 
stress urinary incontinence in women [42].
Currently, MRI is the only imaging modality that provides outstanding func-
tional imaging and anatomical information without the use of ionizing radiation. 
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MR imaging, in the light of rapid technological changes is now faster with less 
movement artifact, and therefore improved image quality and resolution. It allows 
an overall evaluation of the renal parenchyma, excretory cavity, surrounding 
tissue, together with the main vessels. The dynamic contrast enhancement of MRI 
is comparable to renal scintigraphy, and thus ensures a higher contrast spatial and 
temporal resolution. As a result of this inherently superior contrast resolution, MRI 
of the pelvis provides much better anatomical visualization than CT. Furthermore, 
heavy T2-weighted MRI is well suited for imaging of the urinary bladder, since the 
organ is filled with fluid, thus improving bladder visualization. With the advent of 
diffusion weighted MRI, in which imaging and MRI signals are weighted toward 
the diffusion characteristics of water, evaluation of LUT neoplasms, particularly 
bladder cancer has been done [21].
The evident advantages of MRI include the lack of both nephrotoxic contrast 
media and ionizing radiation required for CT, thus making it particularly suitable 
for imaging during renal failure and pregnancy. As a result, indications for MRI 
have been increasing rapidly over the years, and it is currently used as the standard 
imaging modality for staging pelvic cancers. In fact, it is better than CT for the 
anatomical depiction of the bladder wall [22].
3.4 Computed tomography in the assessment of LUTD
The combination of contrast studies and US scan have revolutionized imaging 
of LUT, pinpointing many of the clinical problems originating in the bladder. CT 
has become a vital complementary tool in the investigation of several disorders, 
and crucial for staging cancers. Thus, CT imaging is often employed in the staging 
of bladder cancer, however, its utility in the evaluation of LUTD remains limited. 
CT is the standard imaging modality for the study of adult urology, with or without 
contrast medium for the detection of stones [22]. Key advantages of CT are in 
providing detailed demonstration of overall bladder and pelvic anatomy.
Considering the fact that CT examination is highly radiant, its diagnostic 
potential cannot be transferred carelessly to children, since they have a higher radio 
Figure 2. 
A woman undergoing MRI evaluation of possible urethral diverticulum. Patient had previously undergone 
hysterectomy. Midline sagittal T2-weighted TSE image (6000/116, flip angle, 180°) obtained at rest shows 
no significant prolapse. Solid line represents pubococcygeal line, above which all pelvic organs are located. 
B = bladder, dotted line = urethra, R = rectum. Adapted from Bennett et al. [41].
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sensitivity, smaller structures, lesser representation of adipose tissue, different 
tissue composition and different diseases, contrary to that of adults. Also, CT is not 
suitable for imaging of the urethra, penis and prostate, which are better assessed 
with MRI. That is, CT has limitations when applied to the urinary tract beyond the 
bladder.
Nevertheless, recent technological advancement in CT, incorporating multi-
slice scanning with the possibility of isotropic imaging have further enhanced the 
precision of CT. In isotropic imaging, the block (or voxel) of imaging is acquired 
as a perfect cube, and is thus as dimensionally accurate as possible. Therefore, the 
3D reconstruction of the contrast-filled bladder is rendered precisely, and virtual 
cystoscopy is possible. Thus, CT urography is being touted as one-stop imaging of 
the entire urinary tract, with the potential to replace conventional contrast studies 
and ultrasound, but this however requires further technical developments.
3.5  Positron emission tomography and functional MRI in the assessment of 
LUTD
Positron emission tomography (PET) and functional magnetic resonance 
imaging (fMRI) are powerful non-invasive tools utilized in the study of the supra-
spinal control of the LUT directly through imaging of the brain. fMRI measures 
the changing proportion of deoxygenated and oxygenated hemoglobin in activated 
brain centers, while PET needs the injection of a radioactive isotope that will accu-
mulate in a metabolically active brain region [20]. fMRI has a superb spatial and 
temporal resolution but needs multiple runs of the same event to increase signal-to-
noise ratio, while PET is very sensitive for small changes in neural activity but not 
able to detect rapid changes in brain metabolism [42, 43].
Near infrared spectroscopy (NIRS) is occasionally utilized in the study of 
supraspinal control of the bladder. NIRS takes advantage of the varying concentra-
tions of hemoglobin in the cerebral cortex, but its key disadvantage is the very 
limited resolution for deeper brain structures since it can only accurately measure to 
a depth of 1 cm beneath the skull [44].
In recent years, these different brain imaging techniques have been widely 
spread and optimized, providing a vast amount of literature about nearly every 
human cortical function. Unfortunately, the number of studies that have looked 
into brain control of bladder function is until now still relatively small, but 
nevertheless these studies have provided us with valuable new insights into LUT 
pathophysiology.
3.6  Imaging modalities as surrogates to urodynamic tests for the clinical 
assessment of BOO and DO
Lower urinary tract symptoms alone are usually not sufficient in diagnosing 
common complications of the LUT such as BOO, DO and BPE. Hence, in most 
cases, other investigations are required.
Uroflowmetry, though cheaper and easy to perform in clinical setting, is limited 
by its lack of specificity and inability to differentiate between BOO and detrusor 
underactivity. In much the same way, pressure-flow studies which serve as gold 
standard for diagnosing BOO are able to provide key information on the presence of 
obstruction as well as detrusor contractility. But this come at a cost, as urodynamic 
tests are invasive and require specialist equipment and training to perform tests and 
interpreted results, coupled with associated potential patient morbidity.
Therefore, the search for non-invasive diagnostic tests as potential replace-
ment for these urodynamic tests, especially for the diagnosis of BOO, has been 
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ongoing for many years. As such, parameters such as PVR, free uroflowmetry and 
quantification of prostate volume has been investigated. However, over the past two 
decades, the interest has been on BWT, DWT and bladder wall weight, owing to the 
rationale that BOO and DO are associated with an increase in bladder wall thick-
ness and detrusor hypertrophy. These parameters (BWT, DWT) has been shown by 
several studies to be diagnostic of BOO and DO. Ultrasonography has thus emerged 
as the easiest and non-invasive option capable of measuring BWT, DWT and blad-
der wall weight, thus potentially obviating the need to resort to cumbersome and 
invasive urodynamic tests to diagnose BOO and DO (see Figure 1).
4. Conclusion
Imaging techniques can contribute prominently to our current understanding 
of lower urinary tract dysfunction. A variety of imaging modalities is available to 
visualize the urethra, bladder, prostate and pelvic floor. These techniques can be used 
to enhance our current knowledge of LUT pathophysiology and confirm clinical diag-
nosis, as an alternative diagnostic method to replace invasive urodynamic studies.
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